(Q84342991)
Statements
Exenatide twice daily versus glimepiride for prevention of glycaemic deterioration in patients with type 2 diabetes with metformin failure (EUREXA): an open-label, randomised controlled trial (English)
Baptist Gallwitz
Juan Guzman
Bruno Guerci
Rafael Simó
Bruce R Basson
Andreas Festa
Jacek Kiljański
Hélène Sapin
Michael Trautmann
Guntram Schernthaner